Researchers are working to launch a first-in-human clinical trial to test the approach in patients with cancer who develop ...

Fujifilm’s Life Sciences Group is renaming two of its companies, in a rebranding intended to position parent company Fujifilm as a strategic partner.

NSC51349 selectively inhibits cutaneous HPV replication by targeting viral E2 activity, potentially paving the way for first ...

A new machine learning approach identifies cellular senescence at single-cell resolution across varying cell types and tissue ...

Single-cell RNA-seq (scRNA-seq) has spent the past decade maturing into a foundational technology. Over that time, the ...

Patients on baseline steroids had lower ORR, and markedly shorter PFS survival and OS compared with those not receiving ...

No longer a mere assistant who carries out the commands of DNA, RNA takes the lead in emerging therapeutics.

Two of Cytiva’s top executives offer updates on the company's $1.6 billion in expansion projects worldwide, all to meet growing market demand for its services from developers and manufacturers of ...

If a gene is evolutionarily conserved, that shows it must be doing something important. Otherwise, nature would let it go.

Bacteria and their phage, “are full of mysteries and also lots of really powerful mechanisms that we can study and potentially harness.” ...

Recent developments in protein-protein interactions (PPI) give hope for patients with advanced or untreatable diseases.

Total aggregate value of the drugs generating the highest sales in 2024 rose 6.5% vs. 2023, and jumped 53% over five years.